Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23512
Title: Pre-operative and intra-operative chemical thromboprophylaxis increases bleeding risk following elective cholecystectomy: a multicentre (PROTECTinG) study.
Austin Authors: Liu, David Shi Hao ;Stevens, Sean;Wong, Enoch;Fong, Jonathan;Mori, Krinal;Ward, Salena;Lee, Sharon;Howard, Tess;Jain, Anshini;Gill, Anna S;Beh, Pith S;Slevin, Maeve;Jamel, Wael;Fleming, Nicola ;Bennet, Simon;Chung, Chi;Crowe, Amy;Muralidharan, Vijayaragavan 
Affiliation: Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia
Department of Surgery, Austin Health, Heidelberg, Victoria, Australia
Department of Surgery, Box Hill Hospital, Melbourne, Victoria, Australia
Department of Surgery and Perioperative Medicine, Flinders Medical Centre, Adelaide, South Australia, Australia
Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
The University of Melbourne Department of Surgery, Northern Health, Melbourne, Victoria, Australia
Department of Surgery, Northern Health, Melbourne, Victoria, Australia
Issue Date: 9-Jun-2020
metadata.dc.date: 2020-06-12
Publication information: ANZ Journal of Surgery 2020; online first: 9 June
Abstract: Cholecystectomy is commonly performed in general surgery. Despite guidelines recommending chemical thromboprophylaxis in the perioperative period, the most appropriate time for its initiation is unknown. Here, we investigated whether timing of chemoprophylaxis affected venous thromboembolism (VTE) and bleeding rates post-cholecystectomy. Retrospective review of all elective cholecystectomies performed between 1 January 2018 and 30 June 2019, across seven Victorian hospitals. Clinical VTE was defined as imaging-proven symptomatic disease within 30 days of surgery. Major bleeding was defined as the need for blood transfusion, surgical intervention or >20 g/L fall in haemoglobin from baseline. A total of 1744 cases were reviewed. Chemoprophylaxis was given early (pre- or intra-operatively), post-operatively or not given in 847 (48.6%), 573 (32.9%) and 324 (18.6%) patients, respectively. This varied significantly between surgeons, fellows, trainees and institutions. Clinical VTE occurred in 5 (0.3%) patients and was not associated with chemoprophylaxis timing. Bleeding occurred in 42 (2.4%) patients. Of this, half were major events, requiring surgical control in 5 (11.9%) patients and blood transfusion in 9 (21.4%) patients. Bleeding also extended length of stay (mean (SD), 3.1 (4.0) versus 1.4 (2.2) days, P < 0.001). One bleeding-related mortality was recorded. Importantly, when compared with post-operative (risk ratio 1.46, 95% confidence interval 1.21-1.62) and no (RR 1.23, 95% CI 1.03-1.35) chemoprophylaxis, early usage significantly increased bleeding risk and independently predicted its occurrence. Perioperative chemoprophylaxis is variable among patients undergoing elective cholecystectomy. The rate of clinical VTE post-cholecystectomy is low. Early chemoprophylaxis increases bleeding risk without an appreciable additional protection from VTE.
URI: http://ahro.austin.org.au/austinjspui/handle/1/23512
DOI: 10.1111/ans.15998
ORCID: 0000-0001-8936-4123
0000-0003-3522-1412
0000-0002-2983-4768
0000-0001-8247-8937
PubMed URL: 32516851
Type: Journal Article
Subjects: cholecystectomy
general surgery
prophylaxis
thromboembolism
timing
Appears in Collections:Journal articles

Show full item record

Page view(s)

12
checked on May 5, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.